Predominantly operating in the tech, life sciences, and real estate sectors, DLA Piper LLP (US) leverages vast expertise from its network of offices across Europe, the Middle East, and Asia Pacific when overseeing cross-border IPOs and de-SPAC transactions. The practice’s offering includes bespoke advice to both issuers and underwriters, with co-head Josh Kaufman being a specialist in advising high-growth businesses on strategic development and transformational transactions from his bases in New York and Miami. The other lead, Era Anagnosti, is a corporate governance expert from Washington DC, while in New York, Stephen Alicanti focuses on debt securities and Austin’s Drew Valentine is a corporate finance specialist.
L'éditorial du Legal 500
Distinctions
La satisfaction du client: Qualité de l’avocat et de l’équipe
La satisfaction du client: Facturation et efficacité
Clients clés
- Super Micro Computer, Inc.
- Zealand Pharma A/S
- Silvaco Group, Inc
- Calliditas Therapeutics AB
- Needham & Company, LLC
- BTIG, LLC
- Cantor Fitzgerald & Co.
- Cowen and Company, LLC
- JonesTrading Institutional Services LLC
- Morgan Stanley & Co. LLC
- Liquidia Corporation
- Palomar Specialty Insurance Company
Points forts
Advised Super Micro Computer, Inc. (Supermicro), a global leader in IT solutions and green computing, on its follow-on SEC-registered equity offering of 2,000,000 shares of its common stock at a public offering price of US$875 per share, for gross proceeds of approximately US$1.75 billion.
Acted as international counsel to Calliditas Therapeutics AB (Calliditas), a Swedish biopharmaceutical company, in connection with the tender offer by Asahi Kasei Corporation (Asahi), a Japanese conglomerate, for all of Calliditas’ outstanding shares and American Depositary Shares (ADSs) for an aggregate of US$1.1 billion, which closed in September 2024.
Acted as U.S. counsel to Zealand Pharma, a Danish biotechnology company focused on the discovery and development of peptide-based medicines, in its upsized equity offering of 8.35 million new ordinary shares, which raised gross proceeds of US$1 billion and priced on June 25, 2024.
Responsable de la pratique
Joshua A. Kaufman
Era Anagnosti
Autres avocats clés
Stephen Alicanti
Drew Valentine
Emilio Ragosa
Jeffrey Clark Selman
Bianca Jean LaCaille
Gina Lee